Traws Pharma's total assets for Q1 2025 were $19.06M, a decrease of -23.63% from the previous quarter. TRAW total liabilities were $13.06M for the fiscal quarter, a -76.92% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.